EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Sleeping sickness: perspectives in African trypanosomiasis



Sleeping sickness: perspectives in African trypanosomiasis



Science Progress 79: 183-214



African trypanosomiasis has recently been relegated in the league table of the major infectious diseases. However, in the light of the serious instability of most countries on the African continent, due to civil unrest, political turmoil and unabated fratricidal wars, mass movements of refugees across national borders, to and from sleeping sickness foci, the resurgence and spread of this disease is on the increase. These movements of people en masse are analogous to those which, at the turn of the century led to outbreaks of sleeping sickness killing thousands of people in areas which had previously not experienced this disease. The present situation is compounded by severe budgetary constraints and lack of human resources, making it virtually impossible to undertake surveillance programmes and to deliver health services to already destabilished populations. Current molecular and biochemical studies on the African trypanosome suggest a need for reappraisal of strategies for the diagnosis and treatment of both the chronic and acute forms of sleeping sickness. These studies have also highlighted the complexity of animal trypanosomiasis (nagana). There is an urgent need to understand first, fundamental elements of protection by the immune system, especially in the light of recent findings on the interaction(s), at the outset, between T-cell subsets, B cells, cytokines and parasites and/or parasite derived components (trypanokines), and second, the mechanisms of action of the drugs currently used.

(PDF emailed within 1 workday: $29.90)

Accession: 033411513

Download citation: RISBibTeXText

PMID: 8973165



Related references

Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Tropical Medicine & International Health 12(12): 1422-1432, 2007

Sleeping glands? - The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis). Acta Tropica 104(1): 16-24, 2007

Sleeping sickness (African trypanosomiasis). Irish Journal of Medical Science, no. 285: 729-736, 1949

Sleeping Sickness. African Trypanosomiasis. Gazette Medicale de France 71: 3923-3932, 1964

African trypanosomiasis (sleeping sickness). Meditsinskaia Parazitologiia i Parazitarnye Bolezni: 41-46, 1998

African sleeping sickness--African trypanosomiasis. The story of its conquest. Adler Museum Bulletin 12(1): 3-10, 1986

Human African trypanosomiasis (sleeping sickness). Handbook of clinical neurology Vol 35 Infections of the nervous system Part III: 67-83, 1978

Treatment of African trypanosomiasis (sleeping sickness). La Presse Medicale 68: 881-883, 1960

History of sleeping sickness (African trypanosomiasis). Infectious Disease Clinics of North America 18(2): 231-245, 2004

Agents of African trypanosomiasis (sleeping sickness). Principles and practice of infectious diseases: 2085-2090, 1990

Human African trypanosomiasis (sleeping sickness). Releve Epidemiologique Hebdomadaire 74(30): 245-246, 1999

African trypanosomiasis or sleeping sickness - fact-sheet. Weekly Epidemiological Record 79(32): 297-300, 2004

The diagnosis of African trypanosomiasis (sleeping sickness) in France. La Presse Medicale 68: 529-530, 1960

Imported East African trypanosomiasis (sleeping sickness). Medizinische Welt 28(35): 1378-1381, 1977

Case definitions. African trypanosomiasis (sleeping sickness). Epidemiological Bulletin 24(3): 15-15, 2004